The present invention relates to new, efficient processes for the preparation
of 5-(-2-oxyazolylalkylthio)-2-azacycloalkanoylaminothiazole compounds of formula
I
##STR1##
or a pharmaceutically acceptable salt thereof, wherein:
R is alkyl, aryl or heteroaryl;
R1, R2, R3, R4 and R5 are
each independently hydrogen, alkyl, aryl or heteroaryl;
R6 and R7 are each independently hydrogen, alkyl,
aryl, heteroaryl, halogen, hydroxy or alkoxy;
R8 is hydrogen, alkyl, aryl, heteroaryl, CONR9, R10,
COR11 or COOR12;
R9, R10, R11 and R12 are each
independently hydrogen, alkyl or aryl;
m equals 0 to 5; and
n equals 0 to 5,
which are novel, potent inhibitors of cyclin dependent kinases (cdks). The
present invention further concerns new key intermediate compounds, a quaternary
ammonium salt of formula III and a 2-oxazolylalkyl derivative of formula IX.
|
|
|